Recent Press Releases

NYU Langone Scientists Report Reliable and Highly Efficient Method for Making Stem Cells

NEW YORK, September 18, 2014 – Scientists at NYU Langone Medical Center have found a way to boost dramatically the efficiency of the process for turning adult cells into so-called pluripotent...

UT Southwestern Researchers Discover Novel Class of NAMPT Activators for Neurodegenerative Disease

Newswise — DALLAS, Texas, and South San Francisco, Calif., Sept. 11, 2014 – UT Southwestern Medical Center, 2M Companies, and Calico today announce a new collaboration to advance research...

Protein appears to protect against bone loss in arthritis

AUGUSTA, Ga. – A small protein named GILZ appears to protect against the bone loss that often accompanies arthritis and its treatment, researchers report. Arthritis as well as aging prompt the...

BioFactura and Collaborators to Develop an Ebola Drug Under NIH Partnerships Grant

BioFactura, Inc. is a collaborator on a grant awarded to the Geneva Foundation. Ebola drug development funding will be provided under a Partnerships for Biodefense grant from the National Institutes...

NIH awards aim to improve understanding of cell pathways, development of new therapies

Building on a successful three-year pilot project, the National Institutes of Health has awarded more than $64 million to six research institutions to create a database of human cellular responses,...

Scientists revert human stem cells to pristine state

Rsearchers at EMBL-EBI have resolved a long-standing challenge in stem cell biology by successfully 'resetting' human pluripotent stem cells to a fully pristine state, at point of their...

NEW COMPOUND INHIBITS ENZYME CRUCIAL TO MERS/SARS VIRUSES, WITH A CATCH

WASHINGTON, DC – September 8, 2014 – Scientists at the University of Illinois, Chicago, have identified a compound that effectively inhibits an enzyme crucial to the viruses that cause...

Synthetic Biologics Highlights New Data from C. difficile Program Presented at the 54th ICAAC

ROCKVILLE, Md., Sept. 7, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug programs targeting specific...

SUMMIT PRESENTS NEW POSITIVE PRECLINICAL EFFICACY DATA ON ITS SELECTIVE C DIFFICILE ANTIBIOTIC SMT19969 AT ICAAC 2014

Oxford, UK, 8 September 2014 – Summit (AIM: SUMM), the drug discovery and development company advancing therapies for Duchenne Muscular Dystrophy and C. difficile infection ('CDI'),...

Sanford-Burnham Medical Research Institute And Daiichi Sankyo, Inc. (4568.t) Form AllianceTo Study Novel Drug Targets In Cardiovascular-Metabolic Diseases

ORLANDO, FL--(Marketwired - May 21, 2014) - Sanford-Burnham Medical Research Institute (Sanford-Burnham) and Daiichi Sankyo Co., Ltd. (Daiichi Sankyo) today announced they have entered into a...

Genzyme Announces Multi-Year Multiple Sclerosis Research Collaboration with Leading Academic Medical Center

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today the formation of a research collaboration with Cleveland Clinic focused on developing new...

AstraZeneca and Shenzhen University Health Science Center to collaborate on chronic kidney disease

SHANGHAI, CHINA –AstraZeneca today announced a research collaboration with Shenzhen University Health Science Center. Under the agreement, the partners will undertake pre-clinical research...

CU scientists' discovery could lead to new cancer treatment

AURORA, Colo. (Sept. 2, 2014) – A team of scientists from the University of Colorado School of Medicine has reported the breakthrough discovery of a process to expand production of stem cells...

Boehringer Ingelheim Corporation And Duke Clinical Research Institute Form Collaborative Partnership To Study The Natural History Of Idiopathic Pulmonary Fibrosis (IPF)

RIDGEFIELD, Conn. and DURHAM, N.C., Jan. 30, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Duke Clinical Research Institute (DCRI) have formed a unique collaborative...

Bayer and Peking University Establish New Research Center for Translational Research and Drug Discovery in Beijing

Leverkusen, January 8, 2014 – Bayer HealthCare and Peking University (PKU), Beijing, China, have signed a comprehensive collaboration agreement on a three-year strategic partnership to promote...

Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine

PRINCETON, N.J., Sept. 2, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious...

Surprising discovery: HIV hides in gut, evading eradication

(SACRAMENTO, Calif.) —Researchers at UC Davis have made some surprising discoveries about the body's initial responses to HIV infection. Studying simian immunodeficiency virus (SIV), the...

Mice study shows efficacy of new gene therapy approach for toxin exposures

NORTH GRAFTON, Mass. (August 29, 2014, 2 PM US Eastern Time)—The current method to treat acute toxin poisoning is to inject antibodies, commonly produced in animals, to neutralize the toxin....

Small molecule acts as on-off switch for nature's antibiotic factory

DURHAM, N.C. -- Scientists have identified the developmental on-off switch for Streptomyces, a group of soil microbes that produce more than two-thirds of the world's naturally derived antibiotic...

Study Identifies Protein that Helps Prevent Active Tuberculosis in Infected Patients

UCLA-led study has identified a protein that appears to play a key role in protecting people infected with Mycobacterium tuberculosis — the bacterium that causes tuberculosis — from...